no buyers why, page-9

I wouldn't say the data is mind blowing & it is interim data, the point is the trial hasn't yet progressed for the neccessary time to show full benefit - "CVac may be expected to confer increasing clinical benefit to patients as observation continues; the immune system takes time to build up its strongest response against tumor cells."

On it's own though while it shows it is well tolerated & peforming better than OSC it' really doesn't appear largely better it comes down to "421 days for non-randomized CVac, 365 days for CVac, and 321 days for OSC." - that will only be seen by final data - I wouldn't be suprised if some people where expecting something more mind blowing hence the selling.

So yes it is working, yes it is better than OSC - the trend is right but it needs more time to display the full benefit.